Cellular and functional defects in a mouse model of heart failure.

Heart failure and dilated cardiomyopathy develop in mice that lack the muscle LIM protein (MLP) gene (MLP(-/-)). The character and extent of the heart failure that occurs in MLP(-/-) mice were investigated using echocardiography and in vivo pressure-volume (P-V) loop measurements. P-V loop data were obtained with a new method for mice (sonomicrometry) using two pairs of orthogonal piezoelectric crystals implanted in the endocardial wall. Sonomicrometry revealed right-shifted P-V loops in MLP(-/-) mice, depressed systolic contractility, and additional evidence of heart failure. Cellular changes in MLP(-/-) mice were examined in isolated single cells using patch-clamp and confocal Ca(2+) concentration ([Ca(2+)]) imaging techniques. This cellular investigation revealed unchanged Ca(2+) currents and Ca(2+) spark characteristics but decreased intracellular [Ca(2+)] transients and contractile responses and a defect in excitation-contraction coupling. Normal cellular and whole heart function was restored in MLP(-/-) mice that express a cardiac-targeted transgene, which blocks the function of beta-adrenergic receptor (beta-AR) kinase-1 (betaARK1). These data suggest that, despite the persistent stimulus to develop heart failure in MLP(-/-) mice (i.e., loss of the structural protein MLP), downregulation and desensitization of the beta-ARs may play a pivotal role in the pathogenesis. Furthermore, this work suggests that the inhibition of betaARK1 action may prove an effective therapy for heart failure.

[1]  D. Kass.  Clinical evaluation of left heart function by conductance catheter technique. , 1992, European heart journal.

[2]  T. Skalak,et al.  Accuracy of the conductance catheter for measurement of ventricular volumes seen clinically: effects of electric field homogeneity and parallel conductance , 1997, IEEE Transactions on Biomedical Engineering.

[3]  J. Ross,et al.  Factors influencing indices of left ventricle contractility in the conscious dog. , 1974, Cardiovascular research.

[4]  J. Ross,et al.  Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog. , 1975, The American journal of cardiology.

[5]  W. Lederer,et al.  Relation between the sarcolemmal Ca2+ current and Ca2+ sparks and local control theories for cardiac excitation-contraction coupling. , 1996, Circulation research.

[6]  K. Chien,et al.  Stress Pathways and Heart Failure , 1999, Cell.

[7]  Robert J. Lefkowitz,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[8]  W. Lederer,et al.  Spatial non-uniformities in [Ca2+]i during excitation-contraction coupling in cardiac myocytes. , 1994, Biophysical journal.

[9]  D. Kass,et al.  From 'Emax' to pressure-volume relations: a broader view. , 1988, Circulation.

[10]  P. D. de Tombe,et al.  Curvilinearity of LV end-systolic pressure-volume and dP/dtmax-end-diastolic volume relations. , 1993, The American journal of physiology.

[11]  M. Bristow.  Changes in myocardial and vascular receptors in heart failure. , 1993, Journal of the American College of Cardiology.

[12]  佐川 喜一,et al.  Cardiac contraction and the pressure-volume relationship , 1988 .

[13]  J. Ross,et al.  Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Kass,et al.  Pressure-volume analysis as a method for quantifying simultaneous drug (amrinone) effects on arterial load and contractile state in vivo. , 1990, Journal of the American College of Cardiology.

[15]  W. Lederer,et al.  The control of calcium release in heart muscle. , 1995, Science.

[16]  R. Lefkowitz,et al.  Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. , 1997, The American journal of physiology.

[17]  W. Lederer,et al.  Ca2+ flux through promiscuous cardiac Na+ channels: slip-mode conductance. , 1998, Science.

[18]  W. Lederer,et al.  Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. , 1993, Science.

[19]  Solaro Rj.  Is calcium the 'cure' for dilated cardiomyopathy? , 1999 .

[20]  Cox Ag,et al.  Admissions by the book. , 1977 .

[21]  D. Bers,et al.  Ca2+ diffusion and sarcoplasmic reticulum transport both contribute to [Ca2+]i decline during Ca2+ sparks in rat ventricular myocytes. , 1996, The Journal of physiology.

[22]  S. Snyder,et al.  Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. , 1998, The Journal of clinical investigation.

[23]  W. Lederer,et al.  Calcium Sparks and Excitation–Contraction Coupling in Phospholamban‐Deficient Mouse Ventricular Myocytes , 1997, The Journal of physiology.

[24]  R. Solaro,et al.  Is calcium the 'cure' for dilated cardiomyopathy? , 1999, Nature Medicine.

[25]  Minoru Hongo,et al.  MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.

[26]  R. Solaro,et al.  Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. , 1998, Circulation research.

[27]  R. Lefkowitz,et al.  Heptahelical Receptor Signaling: Beyond the G Protein Paradigm , 1999, The Journal of cell biology.

[28]  M. Bristow.  Mechanism of action of beta-blocking agents in heart failure. , 1997, The American journal of cardiology.

[29]  M. Böhm,et al.  Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. , 1994, Circulation research.

[30]  M. Bristow.  Why does the myocardium fail? Insights from basic science , 1998, The Lancet.

[31]  A. Feldman.  Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium. , 1993, Circulation.

[32]  P. Bjerle,et al.  Increased plasminogen activator inhibitor and tissue plasminogen activator levels in subjects with electrocardiographic abnormality indicative of ischaemic heart disease: a cross-sectional study in Norsjö, Sweden. , 1992, European heart journal.

[33]  M. Martone,et al.  Chronic Phospholamban–Sarcoplasmic Reticulum Calcium ATPase Interaction Is the Critical Calcium Cycling Defect in Dilated Cardiomyopathy , 1999, Cell.

[34]  J M Bland,et al.  Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .

[35]  Dimitrios Georgakopoulos,et al.  The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation , 1999, Nature Medicine.

[36]  J. Port,et al.  Beta-adrenergic blockade in chronic heart failure. , 1998, Scandinavian cardiovascular journal. Supplement.

[37]  R. Lefkowitz,et al.  Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995, Science.

[38]  M. Cho,et al.  Defective β-Adrenergic Receptor Signaling Precedes the Development of Dilated Cardiomyopathy in Transgenic Mice with Calsequestrin Overexpression* , 1999, The Journal of Biological Chemistry.

[39]  J. Ross,et al.  Assessment of Cardiac Function , 1969 .

[40]  W. Lederer,et al.  Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. , 1997, Science.

[41]  R Beyar,et al.  Influence of contractile state on curvilinearity of in situ end-systolic pressure-volume relations. , 1989, Circulation.

[42]  N. Dalton,et al.  Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. , 1998, The Journal of clinical investigation.